PB2564: COVID-19 AND FERRITIN
Main Authors: | Bohdana Kuiavovych, Nadiia Goryainova, Olga Basova, Valentyna Kubarova |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000976948.19995.d0 |
Similar Items
-
PB2666: MAIN DISORDERS AND COAGULATION PARAMETERS IN PATIENTS WITH COVID-19
by: Valentyna Kubarova, et al.
Published: (2023-08-01) -
PB2023: THE LEVEL OF VASCULAR ENDOTHELIAL FACTOR (VEGF) IN THE BLOOD SERUM OF PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS RAEB I).
by: Галина Стародуб, et al.
Published: (2023-08-01) -
2564 Designing for dissemination: Characteristics of Clinical and Translational Science Award (CTSA) hubs as adopters of clinical and translational science innovation
by: Elaine H. Morrato, et al.
Published: (2018-06-01) -
Characterisation of Ferritin–Lymphocyte Ratio in COVID-19
by: Alexander Liu, et al.
Published: (2023-10-01) -
The Role of Ferritin in Assessing COVID-19 Severity
by: Yu. S. Polushin, et al.
Published: (2021-08-01)